Edgestream Partners’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31,802
| Closed | -$335K | – | 854 |
|
|
2023
Q1 | $335K | Sell |
31,802
-8,788
| -22% | -$92.7K | 0.04% | 459 |
|
|
2022
Q4 | $1.38M | Sell |
40,590
-29,252
| -42% | -$992K | 0.15% | 210 |
|
|
2022
Q3 | $3.35M | Sell |
69,842
-1,277
| -2% | -$61.3K | 0.26% | 139 |
|
|
2022
Q2 | $4.05M | Buy |
71,119
+29,539
| +71% | +$1.68M | 0.32% | 93 |
|
|
2022
Q1 | $3.36M | Buy |
41,580
+38,911
| +1,458% | +$3.15M | 0.27% | 126 |
|
|
2021
Q4 | $541K | Buy |
+2,669
| New | +$541K | 0.03% | 384 |
|